MES Solution Integrates With Logix Control Platform

July 18, 2013
System automatically collects data directly from production equipment.

Rockwell Automation released the PharmaSuite v5.0 system for pharmaceutical and biotech production. The new version delivers a single MES solution with the agility to integrate and streamline production not only across multiple production areas and product lines, but also from line to site level.

The PharmaSuite v5.0 system includes improved integration with production equipment, including integration with the Logix control platform and automated batch processing using the PharmaSuite Recipe Designer. The system automatically collects data directly from production equipment, provides automation set points, monitors automation events, and integrates process information into the electronic batch record to reduce the risk for human error that can result from manual data collection.

The PharmaSuite Recipe Designer now supports a greater number of production processes. Its enhanced information-flow design enables access to both definition and run-time information across the entire recipe to give users added insight into real-time production information. The new data types within the expression editor enable users to deploy more sophisticated conditions, rules and calculations so they can more easily customize functionality to meet their needs.

The system also uses a new equipment modeler to define the underlying model and optimize integration across the range of manufacturing types, including biological, secondary, active, discrete assembly, weigh and dispense and packaging. This allows users to define the automation interface, maintain equipment descriptions and specifications and use the new equipment modeler as the foundation for GMP-compliance tracking and automation-integration scenarios. The user interface provides quick access to production information and is optimized to maintain and analyze massive amounts of equipment-related data.

Related Content

Rockwell Automation

Jan. 1, 2000